1.Squamous cell carcinoma arising in eccrine poroma.
Sung Yurl YANG ; Paik Kwon LEE ; Sung Shin WEE ; Eun Joo SUH
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(4):875-879
No abstract available.
Carcinoma, Squamous Cell*
;
Poroma*
2.A Case of Embryonal Cell Carcinoma Originating in the Spermatic Cord.
Chii Min KWON ; Jun Kyu SUH ; Seung Chul YANG ; Jin Moo LEE
Korean Journal of Urology 1983;24(6):1121-1123
We report a case of embryonal cell carcinoma originating in the spermatic cord with review of literature. To our knowledge, this is the first case to be reported in Korea.
Korea
;
Spermatic Cord*
3.Primary Multiple Brain Tumors: Case Report.
In Uk LYO ; Jae Hee SUH ; Yang KWON
Journal of Korean Neurosurgical Society 2001;30(7):925-927
Multiple intracranial tumors of different cell types are rare. We report a case of double primary intracranial tumors of different histologic types: oligodendroglioma, and pituitary adenoma. Von Recklinghausen's disease or other etiologic factors supposedly associated with multiple brain tumors were not recognized in this 36-year-old male patient.
Adult
;
Brain Neoplasms*
;
Brain*
;
Humans
;
Male
;
Neurofibromatosis 1
;
Oligodendroglioma
;
Pituitary Neoplasms
4.Intracranial Plasma Cell Granuloma: A Case Report.
In Uk LYO ; Jae Hee SUH ; Yang KWON
Journal of Korean Neurosurgical Society 2001;30(6):774-776
We report a 35-year old female patient with history of seizure and mass which was confirmed as a plasma cell granuloma, arising in the left parietal area. The mass appeared on magnetic resonance imaging as well circumscribed area of decreased signal that markedly enhanced with administration of the contrast. Pathologically, biopsy showed a mixed cellular population with considerable numbers of plasma cells along with eosinophils and lymphocytes and the tumors was characterized immunohistochemically by polyclonal population of lymphoid cells.
Adult
;
Biopsy
;
Brain
;
Eosinophils
;
Female
;
Granuloma, Plasma Cell*
;
Humans
;
Lymphocytes
;
Magnetic Resonance Imaging
;
Plasma Cells*
;
Plasma*
;
Rabeprazole
;
Seizures
5.Can Early Onset of Disease Be One of the Risk Factors for Low Bone Mineral Density in Patients with Inflammatory Bowel Disease?.
Clinical Endoscopy 2013;46(1):5-6
No abstract available.
Bone Density
;
Humans
;
Risk Factors
6.Endovascular Surgery of Vertebral Artery Dissecting Aneurysm.
Bumn Suk SUH ; Yang KWON ; Byung Duk KWUN
Journal of Korean Neurosurgical Society 1999;28(8):1179-1184
OBJECTIVE: This study was undertaken to demonstrate the usefulness of endovascular technique in treatment of vertebral artery dissecting aneurysms. METHODS: The clinical characteristics of vertebral artery dissecting aneurysms were reviewed in 11 patients with particular focus on clinical presentation, angiographic feature and outcome. RESULTS: All patients underwent the GDC embolization. One of them was managed with surgical trapping after failure of GDC embolization and the other with GDC embolization after failure of stent insertion. Nine patients were recovered with intact neurological feature, one patient died as result of sepsis and ARDS, and one patient was suffered from cerebellar infarction. CONCLUSION: Although the timing of the procedure and site of occlusion remain controversial, proximal GDC occlusion of vertebral artery appears to be a safe and effective therapy for patients with vertebral artery dissecting aneurysm. This procedure provides an important, less invasive alternative for this condition.
Aneurysm, Dissecting*
;
Endovascular Procedures
;
Humans
;
Infarction
;
Sepsis
;
Stents
;
Vertebral Artery*
8.Urinary Nuclear Matrix Protein ( NMP 22 ) in the Detection of Transitional Cell Carcinoma of the Bladder.
Soo Bang RYU ; Bong Ryoul OH ; Soon Pal SUH ; Dong Deuk KWON ; Je Woong RYU ; Yang Il PARK
Journal of the Korean Cancer Association 1998;30(2):378-383
PURPOSE: The detection of bladder cancers by noninvasive techniques remains an unsolved problem. We evaluate the availability of an immunoassay for urinary nuclear matrix protein, NMP 22, as an indicator for transitional cell carcinoma of the bladder. MATERIALS AND METHODS: Three groups of subjects participated in this trial of NMP 22: 22 patients with transitional cell carcinoma (group 1), 12 patients with urinary tract infection (group 2) and 31 healthy volunteers (group 3). NMP 22 was determined by ELISA using a commercial test kit (NMP 22 Test Kit, Matritech Inc., USA), We compared urinary NMP 22 levels to the grade, stage, cytology and DNA flowcytometry of transitional cell carcinoma of bladder. RESULTS: NMP 22 values in these 3 groups were significantly different (group 1, median 24.81 U/mL; group 2, median 8.41 U/mL; and group 3, median 5.12 U/mL; Mann-Whitney U test for differences between 3 medians, p < 0.05). The patients with transitional cell carcinoma had significantly greater urinary NMP 22 levels than those with no evidence of tumor (Mann-Whitney U test for differences between 2 medians, p<0.01). There was no zelationship between the urinary NMP 22 levels and tumor grade, stage, cytology or DNA flowcytometry. CONCLUSIONS: It is possible that urinary NMP 22 could improve the detection of bladder transitional cell carcinoma.
Carcinoma, Transitional Cell*
;
DNA
;
Enzyme-Linked Immunosorbent Assay
;
Healthy Volunteers
;
Humans
;
Immunoassay
;
Nuclear Matrix*
;
Urinary Bladder Neoplasms
;
Urinary Bladder*
;
Urinary Tract Infections
9.Clinical Evaluation of Argatroban in the Treatment of Chronic Arterial Occlusion Disease.
Woo Hyung KWUN ; Bo Yang SUH ; Koing Bo KWUN ; Tae Won KWON ; Geun Eun KIM ; Sang Hun CHO
Journal of the Korean Society for Vascular Surgery 2001;17(2):266-273
PURPOSE: The main object of treatment in chronic occlusive arterial disease is to increase blood flow and to prevent progress of ischemic ulcer. In case of the symptoms and signs such as rest pain, ischemic ulcer and gangrene with poor angiographic distal run-off, conservative medical treatment is recommended. Argatroban (Novastan(R) ) has an arginine structure, is the first selective antithrombin in the world, showing the inhibitory effect of thrombin-induced fibrin formation, platelet aggregation and vasoconstriction. METHOD: From September 1995 to January 1999, 39 patients with chronic arterial occlusion as subjects, ulcers, resting pain and feelings of coldness participated in Novastan treatment in 3 institutions (Department of Surgery, Yeungnam University College of Medicine, Department of Surgery Vascular Division, Ulsan University College of Medicine and Asan Medical Center, Department of Surgery, Gachon Medical School) and 30 patients completed the study:thromboangitis obliterance (TAO) in 19 and atherosclerosis obliterans (ASO) in 11 cases. Administration dose was 20 mg (2 amples, q.d or b.i.d) and medicated for consecutive 4 weeks. To detect the changes of symptoms, ulcer size and occurrence of side effects, inquiries, photography and laboratory tests were checked at prior to medication and 2, 3 and 4 weeks after medication. RESULT: There were 29 men and 1 women, ranging in age from 18 to 80 years old with mean of 50 years old and in body weight from 44 to 86 kg with mean of 64 kg. Improvement rate on ulcer size and granulation appearance was 73.3% (22 cases/30) and 86.7% (26 cases/30) respectively. General improvement rates were 76.7% (23 cases/30), general safety rates were 97.4% (38 cases/39), and utility rates were 70.0% (21 cases/30). Side effects were observed in 3 cases (7.7%), and abnormal changes in laboratory tests were observed for 15 items in 9 cases. But there noted no significant side effects and abnormalities in laboratory tests. CONCLUSION: Argatroban had a beneficial effect in improving such clinical symptoms as ischemic ulcer, resting pain and the feeling of coldness, accompanying chronic arterial occlusion, it causes no serious side effects and it shows high clinical utility.
Aged, 80 and over
;
Arginine
;
Atherosclerosis
;
Body Weight
;
Chungcheongnam-do
;
Female
;
Fibrin
;
Gangrene
;
Humans
;
Male
;
Middle Aged
;
Photography
;
Platelet Aggregation
;
Ulcer
;
Ulsan
;
Vasoconstriction
10.Detection of Circulating Cancer Cells in Prostate Cancer Patients using Reverse Transcriptase Polymerase Chin Reaction for prostate Specific Membrane Antigen mRNA.
Yang Il PARK ; Dong June CHOI ; Dong Deuk KWON ; Bong Ryoul OH ; Woo Hyun LIM ; Soon Pal SUH ; Soo Bang RYU
Korean Journal of Urology 2000;41(4):480-485
No abstract available.
Chin*
;
Humans
;
Membranes*
;
Prostate*
;
Prostatic Neoplasms*
;
RNA, Messenger*
;
RNA-Directed DNA Polymerase*